Malignant Testicular Neoplasm — Trials

Malignant Testicular Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

177 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 43
Recruiting: 26
Ph III recruiting: 3
Growth YoY: —
Industry share: 2%
Top sponsor: University Health Network, Toronto
Termination share: 35.3%
Trials / 1,000 deaths: 80.1 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (23)

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06191575	7 Tesla MRI Neuroimaging in Testicular Cancer Patients With Hypogonadism and on Androgen Replacement Therapy	suspended	—	10	University of Southern CaliforniaOTHER	1	Jun 5, 2026	clinicaltrials

Data updated 22 days agoSource updated Jun 5, 2026source: clinicaltrials